Tag Archives: Martin Markowitz

Long-acting drug effectively prevents HIV-like infection in monkeys

Long-acting drug effectively prevents HIV-like infection in monkeysBecause cabotegravir would require only one injection every three months, researchers hope this new drug, which has begun clinical testing, could improve some patients’ ability to take HIV prevention medication properly. More »

Tags: , , , , , , , ,

HIV-1 kills immune cells in the gut that may never bounce back

People with HIV have been living longer, healthier lives since the development of highly active antiretroviral therapy (or HAART) in 1995. In fact, most patients on the drug regimen do so well that, according to blood tests, their immune cells appear to return to pre-HIV levels. But two new studies from Rockefeller University and the Aaron Diamond AIDS Research Center show that within the gastrointestinal tract, recovery of immune cells is incomplete despite years of prolonged treatment, suggesting the need for additional ways to monitor immune system health, and the need for hypervigilance as HIV-positive patients live into their forties, fifties, sixties and beyond. More »

Tags: ,

Rockefeller and Aaron Diamond Researchers Say Resistance to HIV Drugs May Be Higher Than Previously Thought

A study of patients infected with the AIDS virus revealed that about one in six was carrying a strain that is resistant to at least one of the drugs targeting HIV, researchers report from the Aaron Diamond AIDS Research Center, an affiliate of The Rockefeller University. Lead author Daniel Boden, M.D., and 11 colleagues report the research as the cover story in the Sept. 22-29 issue of the Journal of the American Medical Association. The authors suggest that further research should try to establish whether AIDS therapy structured around HIV-resistance testing would be more effective than current methods. More »

Tags: , ,